Tuberous sclerosis: Difference between revisions

	Tuberous sclerosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Differentiating Tuberous sclerosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Tuberous sclerosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tuberous sclerosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tuberous sclerosis
CDC on Tuberous sclerosis
Tuberous sclerosis in the news
Blogs on Tuberous sclerosis
Directions to Hospitals Treating Tuberous sclerosis
Risk calculators and risk factors for Tuberous sclerosis

← Older edit

VisualWikitext

Latest revision as of 17:51, 23 June 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Any Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Case Studies

Case #1

Template:WH Template:WS

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Infobox_Disease |
+{{Tuberous sclerosis}}
-  Name           = Tuberous sclerosis|
+{{CMG}}; {{AE}} {{Jose}}
-  Image          = TuberousSclerosis-Rayer.jpg|
-  Caption        = Earliest illustration, from [[Pierre François Olive Rayer|Rayer]]'s atlas of skin diseases, 1835.|
+==[[Tuberous sclerosis overview|Overview]]==
-}}
+==[[Tuberous sclerosis historical perspective|Historical Perspective]]==
-{{Tuberous sclerosis}}
+==[[Tuberous sclerosis classification|Classification]]==
-'''For patient information on this page, click [[Tuberous sclerosis (patient information)|here]]'''
+==[[Tuberous sclerosis pathophysiology|Pathophysiology]]==
-{{CMG}}; {{AE}} {{RT}}
+==[[Tuberous sclerosis causes|Causes]]==
-{{SK}} Tuberous sclerosis complex, TSC, Bourneville disease, Bourneville-Pringle syndrome, epiloia
+==[[Tuberous sclerosis differential diagnosis|Differentiating Any Disease from other Diseases]]==
-===Imaging===
+==[[Tuberous sclerosis epidemiology and demographics|Epidemiology and Demographics]]==
-==Treatment==
-===Medical therapy===
-'''Drug therapy''' for some of the manifestations of TSC is currently in the developmental stage.<ref>{{cite journal | pmid = 16868562 | doi=10.1038/sj.ejhg.5201625 | volume=14 | issue=10 | title=Tuberous sclerosis | year=2006 | month=October | author=Yates JR | journal=Eur. J. Hum. Genet. | pages=1065–73}}</ref> For example, a 2008 study found that treatment with [[rapamycin]] rescued learning and memory deficits in a mouse model of tuberous sclerosis.<ref>{{cite journal |journal= Nat Med |year=2008 |title= Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis |author= Ehninger D, Han S, Shilyansky C ''et al.'' |doi=10.1038/nm1788 |pmid=18568033 |laysummary=http://www.sciencedaily.com/releases/2008/06/080622224428.htm |laysource= Science News |laydate=23 June 2008 |volume= 14 |pages= 843–8 |issue= 8 |pmc= 2664098}}</ref> [[Community TSC]] is a distributed computing project to find drugs to treat TSC.{{Citation needed|date=June 2008|laysummary=http://www.childhooddiseases.org/community_tsc.html}}
-The patients usually have relapse of symptoms in the clinical course. Unless any vital function is affected, life expectancy is good. Majority of patients will require some medications to control symptoms, e.g., anti-epileptics to control seizures.
-In 2010 [[everolimus]] was approved for the treatment of [[subependymal giant cell astrocytoma]].
-Other drugs used include:
+==[[Tuberous sclerosis risk factors|Risk Factors]]==
-* [[Vigabatrin]]<ref name="pmid19557123">{{cite journal |author=Tsao CY |title=Current trends in the treatment of infantile spasms |journal=Neuropsychiatr Dis Treat |volume=5 |issue= |pages=289–99 |year=2009 |pmid=19557123 |pmc=2695218 |doi= |url=http://www.dovepress.com/articles.php?article_id=3150}}</ref>
-* [[ACTH]]<ref name="Shorvon2010">{{cite book|author=Simon D. Shorvon|title=Handbook of Epilepsy Treatment|url=http://books.google.com/books?id=ce1YGxllLsgC&pg=PA93|accessdate=11 October 2010|year=2010|publisher=John Wiley and Sons|isbn=978-1-4051-9818-9|pages=93–}}</ref>
-'''Facial angiofibromas''' is a socially embarrassing rash that starts to appear during childhood and can be removed using [[dermabrasion]] or laser treatment.
+==[[Tuberous sclerosis screening|Screening]]==
-===Surgical therapy===
+==[[Tuberous sclerosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
-'''Ungual''' or '''subungual fibromas''' may need to be surgically removed if they enlarge or cause bleeding.
-==References==
+==Diagnosis==
-{{Reflist|2}}
+[[Tuberous sclerosis history and symptoms|History and Symptoms]] | [[Tuberous sclerosis physical examination|Physical Examination]] | [[Tuberous sclerosis laboratory findings|Laboratory Findings]] | [[Tuberous sclerosis electrocardiogram|Electrocardiogram]] | [[Tuberous sclerosis chest x ray|Chest X Ray]] | [[Tuberous sclerosis CT|CT]] | [[Tuberous sclerosis MRI|MRI]] | [[Tuberous sclerosis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Tuberous sclerosis other imaging findings|Other Imaging Findings]] | [[Tuberous sclerosis other diagnostic studies|Other Diagnostic Studies]]
-====Support Groups====
+==Treatment==
-* United Kingdom: [http://www.tuberous-sclerosis.org/ The Tuberous Sclerosis Association]. Awareness month is October.
+[[Tuberous sclerosis medical therapy|Medical Therapy]] | [[Tuberous sclerosis surgery|Surgery]] | [[Tuberous sclerosis primary prevention|Primary Prevention]] | [[Tuberous sclerosis secondary prevention|Secondary Prevention]] | [[Tuberous sclerosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Tuberous sclerosis future or investigational therapies|Future or Investigational Therapies]]
-* United States: [http://www.tsalliance.org/ Tuberous Sclerosis Alliance]. Awareness month is May.
-* Canada: [http://www.tscst.org/ Tuberous Sclerosis Canada]. Awareness month is May.
-* Australasia: [http://www.atss.org.au/ Australasian Tuberous Sclerosis Society].
-* Brazil: [http://www.abet.org.br/entrada.htm Associação Brasileira de Esclerose Tuberosa (''Brazilian Tuberous Sclerosis Association'')] {{pt icon}}
-* Taiwan: [http://www.ttsc.org.tw Taiwan Tuberous Sclerosis Complex]
-{{Phakomatoses and other congenital malformations not elsewhere classified}}
+==Case Studies==
+[[Tuberous sclerosis case study one|Case #1]]
-[[Category:Genetic disorders]]
-[[Category:Disease]]
-[[Category:Neurology]]
-[[es:Esclerosis tuberosa]]
+[[Category:Projects]]
-[[fr:Sclérose tubéreuse de Bourneville]]
+[[Category:Help]]
-[[ja:結節性硬化症]]
-[[pl:Stwardnienie guzowate]]
-[[zh:结节性硬化症]]
-{{WikiDoc Help Menu}}
+{{WH}}
-{{WikiDoc Sources}}
+{{WS}}

Tuberous sclerosis: Difference between revisions

Latest revision as of 17:51, 23 June 2020

Diagnosis

Treatment

Case Studies

Navigation menu

Search